Reliance Industries has incorporated a new subsidiary in the UAE for trading in crude oil, petroleum products and agricultural commodities.

Natco Pharma said based on the ANDA filing date, the company believes that it is eligible for 180 days of sole generic marketing exclusivit...

Natco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celg...

"Breckenridge Pharmaceutical Inc (BPI) has received final approval for its abbreviated new drug application (ANDA) for Everolimus tablets f...

"Breckenridge Pharmaceutical Inc. has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide Capsules fro...

The Indian generic drug maker had partnered with Breckenridge Pharmaceutical for marketing its Carfilzomib injection in the US market.

Alembic Pharma had received approval of its ANDA of desvenlafaxine succinate extended release tablets of strengths 50 mg and 100 mg in June...

Natco Pharma has received final approval from the US Food and Drug Administration (USFDA) for generic version of Armodafinil tablets.

Breckenridge had filed its abbreviated new drug application (ANDA) with a Paragraph IV certification to obtain approval to manufacture.

The drug, used to prevent organ rejection after a kidney or liver transplant, generated sales of $43.5 mn for the 12-mth period ending July.

UCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.

Natco said the drug shipments were already made and the product is being marketed by its partner Breckenridge Pharmaceuticals in the US mar...

Shares of Alembic Pharma surged by over 4% after the co said it along with Breckenridge Pharma Inc, USA has settled a patent case with Nova...